19 April 2022
S-VENTURES PLC
("S-Ventures" or the "Company")
Issue of Shares
S-Ventures, the Company investing in and growing exciting brands across the natural, wellness and food-tech category, announced the completion of the acquisition of Market Rocket Limited on 11 April 2022. In satisfaction of the share element of the consideration, the Company has issued 2,142,857 new ordinary shares to the vendors.
Application has been made for the 2,142,857 new ordinary shares to be admitted to trading on AQSE which is expected to occur on, or around, 22 April ("Admission").
Following Admission of the new ordinary shares, the issued share capital of the Company will be 119,802,943 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interests in, or change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
For further information, please contact:
| The Company Robert Hewitt (Chief Financial Officer) Scott Livingston (Chief Executive Officer) |
+44 (0) 1932 400 224 |
|
|
|
| AQSE Corporate Adviser and Broker: VSA Capital Limited Andrew Raca/Pascal Wiese - Corporate Finance Andrew Monk - Corporate Broking |
+44 (0) 20 3005 5000 |
|
|
|
| IFC Advisory (Financial PR) Graham Herring Tim Metcalfe Florence Chandler |
+44 (0) 20 3934 6630 |
About S-Ventures
S-Ventures is listed on UK AQUIS Exchange (Ticker Code "SVEN"). The Company seeks to identify investment opportunities in the health & wellness, organic food and wellbeing sectors within the UK and Europe, adding value by providing capital and expertise to the target companies. The experience and operational skills of the Board led by Scott Livingston (CEO) are intended to act as an accelerator to smaller brands that have a solid foundation and platform but may lack the skills and capital. The main objectives are to cross-fertilise opportunities between the target companies and scale the individual entities and look for exit opportunities and/or synergistic collaborations through scaling we seek to create significant value for all stakeholders. Since listing on AQSE in September 2020, the Company has acquired significant interests in seven companies.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.